PhaseV is a technology company that redefines clinical development at scale with its enterprise-ready, multi-modal AI/ML platform. With over $65M raised from top investors, we are poised to make a significant impact on how drugs are developed and brought to market - ultimately helping effective treatments reach patients faster.
In PhaseV Trials’s own words, from its job postings.